These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. CSF3R T618I, SETBP1 G870S, SRSF2 P95H, and ASXL1 Q780* tetramutation co-contribute to myeloblast transformation in a chronic neutrophilic leukemia. Qian Y, Chen Y, Li X. Ann Hematol; 2021 Jun; 100(6):1459-1461. PubMed ID: 33822276 [Abstract] [Full Text] [Related]
4. Clinical significance of CSF3R, SRSF2 and SETBP1 mutations in chronic neutrophilic leukemia and chronic myelomonocytic leukemia. Ouyang Y, Qiao C, Chen Y, Zhang SJ. Oncotarget; 2017 Mar 28; 8(13):20834-20841. PubMed ID: 28209919 [Abstract] [Full Text] [Related]
5. CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia. Pardanani A, Lasho TL, Laborde RR, Elliott M, Hanson CA, Knudson RA, Ketterling RP, Maxson JE, Tyner JW, Tefferi A. Leukemia; 2013 Sep 28; 27(9):1870-3. PubMed ID: 23604229 [Abstract] [Full Text] [Related]
8. A CSF3R T618I Mutation in a Patient with Chronic Neutrophilic Leukemia and Severe Bleeding Complications. Mitsumori T, Komatsu N, Kirito K. Intern Med; 2016 Sep 28; 55(4):405-7. PubMed ID: 26875968 [Abstract] [Full Text] [Related]
16. Neutrophilic progression in a case of polycytemia vera mimicking chronic neutrophilic leukemia: clinical and molecular characterization. Castelli R, Cugno M, Gianelli U, Pancrazzi A, Vannucchi AM. Pathol Res Pract; 2015 Apr 01; 211(4):341-3. PubMed ID: 25480691 [Abstract] [Full Text] [Related]
17. Chronic neutrophilic leukemia: 2018 update on diagnosis, molecular genetics and management. Elliott MA, Tefferi A. Am J Hematol; 2018 Aug 01; 93(4):578-587. PubMed ID: 29512199 [Abstract] [Full Text] [Related]
18. [CSF3R, ASXL1,SETBP1, JAK2 V617F and CALR mutations in chronic neutrophilic leukemia]. Cui Y, Li B, Jiang Q, Xu Z, Qin T, Zhang P, Zhang Y, Xiao Z. Zhonghua Xue Ye Xue Za Zhi; 2014 Dec 01; 35(12):1069-73. PubMed ID: 25543699 [Abstract] [Full Text] [Related]
19. Analysis of CSF3R mutations in atypical chronic myeloid leukemia and other myeloid malignancies. Kim SY, Song IC, Kim J, Kwon GC. Ann Diagn Pathol; 2024 Aug 01; 71():152317. PubMed ID: 38642470 [Abstract] [Full Text] [Related]
20. The Colony-Stimulating Factor 3 Receptor T640N Mutation Is Oncogenic, Sensitive to JAK Inhibition, and Mimics T618I. Maxson JE, Luty SB, MacManiman JD, Paik JC, Gotlib J, Greenberg P, Bahamadi S, Savage SL, Abel ML, Eide CA, Loriaux MM, Stevens EA, Tyner JW. Clin Cancer Res; 2016 Feb 01; 22(3):757-64. PubMed ID: 26475333 [Abstract] [Full Text] [Related] Page: [Next] [New Search]